These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19352084)

  • 21. Myeloproliferative disorders carrying the t(8;9) (PCM1-JAK2) translocation.
    Bousquet M; Brousset P
    Hum Pathol; 2006 Apr; 37(4):500; author reply 500-2. PubMed ID: 16564930
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular-genetic aspects of leukaemogenesis.
    Fey MF
    Schweiz Med Wochenschr Suppl; 1991; 43():33-9. PubMed ID: 1843036
    [No Abstract]   [Full Text] [Related]  

  • 23. BCR-ABL positive chronic myeloid leukemia with concurrent JAK2(V617F) positive myelodysplastic syndrome/myeloproliferative neoplasm (RARS-T).
    Gattenlohner S; Völker HU; Etschmann B; Einsele H; Müller-Hermelink HK
    Am J Hematol; 2009 May; 84(5):306-7. PubMed ID: 18951468
    [No Abstract]   [Full Text] [Related]  

  • 24. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
    Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C
    Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of a BCR-ABL translocation in a patient with the JAK2V617F mutation: evidence for secondary acquisition of BCR-ABL in the JAK2V617F clone.
    Yamada O; Mahfoudhi E; Plo I; Ozaki K; Nakatake M; Akiyama M; Yamada H; Kawauchi K; Vainchenker W
    J Clin Oncol; 2014 Jul; 32(21):e76-9. PubMed ID: 24516035
    [No Abstract]   [Full Text] [Related]  

  • 26. Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms.
    Kosmider O; Gelsi-Boyer V; Slama L; Dreyfus F; Beyne-Rauzy O; Quesnel B; Hunault-Berger M; Slama B; Vey N; Lacombe C; Solary E; Birnbaum D; Bernard OA; Fontenay M
    Leukemia; 2010 May; 24(5):1094-6. PubMed ID: 20376084
    [No Abstract]   [Full Text] [Related]  

  • 27. p38 mitogen-activated protein kinase has different degrees of activation in myeloproliferative disorders and myelodysplastic syndromes.
    Shahjahan M; Dunphy CH; Ewton A; Zu Y; Monzon FA; Rice L; Chang CC
    Am J Clin Pathol; 2008 Oct; 130(4):635-41. PubMed ID: 18794058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABL.
    Mali RS; Ramdas B; Ma P; Shi J; Munugalavadla V; Sims E; Wei L; Vemula S; Nabinger SC; Goodwin CB; Chan RJ; Traina F; Visconte V; Tiu RV; Lewis TA; Stern AM; Wen Q; Crispino JD; Boswell HS; Kapur R
    Cancer Cell; 2011 Sep; 20(3):357-69. PubMed ID: 21907926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focus on myeloproliferative diseases and myelodysplastic syndromes.
    Van Etten RA; Shannon KM
    Cancer Cell; 2004 Dec; 6(6):547-52. PubMed ID: 15607959
    [No Abstract]   [Full Text] [Related]  

  • 30. Two cases of myeloproliferative neoplasm with a concurrent JAK2 (V617F) mutation and BCR/ABL translocation without chronic myelogenous leukemia phenotype acquisition during hydroxyurea treatment.
    Park SH; Chi HS; Cho YU; Jang S; Park CJ; Kim DY; Lee JH; Lee KH
    Ann Lab Med; 2013 May; 33(3):229-32. PubMed ID: 23667855
    [No Abstract]   [Full Text] [Related]  

  • 31. Different lineage involvement in myelodysplastic/myeloproliferative disease with combined MPLW515L and JAK2V617F mutation.
    Hussein K; Theophile K; Buhr T; Beller A; Kreipe H; Bock O
    Br J Haematol; 2009 Jun; 145(5):673-5. PubMed ID: 19344408
    [No Abstract]   [Full Text] [Related]  

  • 32. JAK2 46/1 haplotype predisposes to splanchnic vein thrombosis-associated BCR-ABL negative classic myeloproliferative neoplasms.
    Villani L; Bergamaschi G; Primignani M; Rosti V; Carolei A; Poletto V; Catarsi P; Spolverini A; Vannucchi AM; Barosi G
    Leuk Res; 2012 Jan; 36(1):e7-9. PubMed ID: 21890200
    [No Abstract]   [Full Text] [Related]  

  • 33. Myelodysplastic/myeloproliferative disorders.
    Malcovati L; Cazzola M
    Haematologica; 2008 Jan; 93(1):4-6. PubMed ID: 18166777
    [No Abstract]   [Full Text] [Related]  

  • 34. PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation.
    Murati A; Gelsi-Boyer V; Adélaïde J; Perot C; Talmant P; Giraudier S; Lodé L; Letessier A; Delaval B; Brunel V; Imbert M; Garand R; Xerri L; Birnbaum D; Mozziconacci MJ; Chaffanet M
    Leukemia; 2005 Sep; 19(9):1692-6. PubMed ID: 16034466
    [No Abstract]   [Full Text] [Related]  

  • 35. FAK silencing inhibits leukemogenesis in BCR/ABL-transformed hematopoietic cells.
    Le Y; Xu L; Lu J; Fang J; Nardi V; Chai L; Silberstein LE
    Am J Hematol; 2009 May; 84(5):273-8. PubMed ID: 19358301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New molecular insights in myelodysplastic and myeloproliferative disorders.
    Emanuel PD
    Clin Adv Hematol Oncol; 2005 Jun; 3(6):459-60. PubMed ID: 16167021
    [No Abstract]   [Full Text] [Related]  

  • 37. Clonality in hematopoietic disorders.
    Hotta T
    Int J Hematol; 1997 Dec; 66(4):403-12. PubMed ID: 9479867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
    Haferlach C; Rieder H; Lillington DM; Dastugue N; Hagemeijer A; Harbott J; Stilgenbauer S; Knuutila S; Johansson B; Fonatsch C
    Genes Chromosomes Cancer; 2007 May; 46(5):494-9. PubMed ID: 17311250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease.
    Scheijen B; Griffin JD
    Oncogene; 2002 May; 21(21):3314-33. PubMed ID: 12032772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytogenetics of chronic myeloproliferative disorders and related myelodysplastic syndromes.
    Adeyinka A; Dewald GW
    Hematol Oncol Clin North Am; 2003 Oct; 17(5):1129-49. PubMed ID: 14560778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.